当前位置:首页 - 行情中心 - 泽璟制药-U(688266) - 财务分析

泽璟制药-U

(688266)

  

流通市值:251.39亿  总市值:251.39亿
流通股本:2.65亿   总股本:2.65亿

泽璟制药-U(688266)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润-0.96亿元,每股收益-0.35元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益114901.39万元,未分配利润-221015.87万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产301337.74万元,负债186436.36万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入593,440,129.02375,650,273.55167,641,962.39532,954,371.3
营业总成本720,231,851.57475,168,324.66224,891,718.58726,897,941.91
其他经营收益
营业利润-96,762,629.52-76,731,169.28-30,017,022.32-155,043,183.78
利润总额-98,319,633.96-77,414,988.02-30,317,022.32-155,047,806.79
净利润-95,596,820.94-75,569,945.5-29,313,362.27-150,298,322.91
每股收益
其他综合收益-598,227.97-477,198.95140,191.46-8,749,199.69
综合收益总额-96,195,048.91-76,047,144.45-29,173,170.81-159,047,522.6
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计2,505,923,345.632,551,629,069.42,496,560,281.492,575,898,809.8
非流动资产:
非流动资产合计507,454,092.73447,574,282.64421,263,599.42428,715,474.18
资产总计3,013,377,438.362,999,203,352.042,917,823,880.913,004,614,283.98
流动负债:
流动负债合计1,354,855,501.351,342,223,646.41,325,481,564.641,373,445,525.83
非流动负债:
非流动负债合计509,508,061.13480,364,269.2368,612,453.87378,568,209.03
负债合计1,864,363,562.481,822,587,915.61,694,094,018.511,752,013,734.86
所有者权益(或股东权益):
归属于母公司股东权益合计1,149,013,875.881,176,615,436.441,226,013,046.531,253,857,931.48
股东权益合计1,149,013,875.881,176,615,436.441,223,729,862.41,252,600,549.12
负债和股东权益合计3,013,377,438.362,999,203,352.042,917,823,880.913,004,614,283.98
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计766,141,565.65475,143,193.87216,781,433.79872,829,012.32
经营活动现金流出小计782,875,487.51492,163,469.95223,034,586.21834,624,467.53
经营活动产生的现金流量净额-16,733,921.86-17,020,276.08-6,253,152.4238,204,544.79
投资活动产生的现金流量:
投资活动现金流入小计65,943,533.3317,373,2007,177,4001,217,088,569.19
投资活动现金流出小计132,497,229.0679,715,800.3633,808,123.123,062,189,956.33
投资活动产生的现金流量净额-66,553,695.73-62,342,600.36-26,630,723.12-1,845,101,387.14
筹资活动产生的现金流量:
筹资活动现金流入小计616,021,145.08431,521,145.08141,321,903.341,288,618,503.6
筹资活动现金流出小计616,706,142405,608,309.59173,118,011.281,339,934,919.14
筹资活动产生的现金流量净额-684,996.9225,912,835.49-31,796,107.94-51,316,415.54
汇率变动对现金及现金等价物的影响-527,602.39-453,654.23-9,211.92-2,298,440.51
现金及现金等价物净增加额-84,500,216.9-53,903,695.18-64,689,195.4-1,860,511,698.4
期末现金及现金等价物余额132,765,276.18163,361,797.9152,576,297.68217,265,493.08
补充资料:
现金及现金等价物的净增加额--53,903,695.18--1,860,511,698.4
最新报告期:2025-11-01
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
华安证券谭国超-0.410.722.122025-11-01
野村东方国际证券孔令岩,肖鸿德-0.220.641.752025-10-31
天风证券杨松,曹文清-0.070.481.022025-09-27
华源证券刘闯-0.360.442.122025-09-04
信达证券唐爱金-0.69-0.020.482025-09-03
TOP↑